IndiaMTF — home
Stock

ACUTAAS

Acutaas Chemicals Limited
Health Technology

Daily Margin Trading Facility book for ACUTAAS across NSE and BSE, from 09 Jun 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹100 Cr
as of 10 Sep 2026
Rank in book
#383
255 days tracked
Share of book
0.06%
of the whole NSE + BSE book
Peak funded
₹142 Cr
on 24 Jul 2026
Largest single-day addition
+₹26 Cr
on 15 Apr 2026
Largest single-day unwind
−₹17 Cr
on 29 Jan 2026

NSE & BSE split

How ACUTAAS’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹95 Cr · 95.0%BSE ₹5 Cr · 5.0%

MTF vs Price

Margin-funded outstanding for ACUTAAS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹3,383.70
as of 11 Sep 2026
Price, 30 days
+9.0%
adjusted for splits and bonuses
Delivery, 20-day avg
52.1%
of traded volume actually settled
Sessions to unwind
2.3
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day−₹9−8.5%−7.8%
−28,531
+6.5%unwinding into strength
10 days−₹11−10.0%−8.9%
−32,900
+3.7%unwinding into strength
30 days−₹41−29.1%−26.2%
−1,19,378
+6.7%unwinding into strength
90 days+₹5+5.0%−11.1%
−42,084
+9.7%unwinding into strength
180 days+₹40+65.6%−2.0%
−7,043
+60.2%unwinding into strength
1 year+₹58+140.4%−14.5%
−56,767
+215.6%unwinding into strength
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where ACUTAAS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

ACUTAAS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026100−₹90.06%383
09 Sep 2026109−₹10.07%353
08 Sep 2026111+₹00.07%346
07 Sep 2026111−₹30.07%346
04 Sep 2026113+₹10.07%336
03 Sep 2026112−₹20.07%334
02 Sep 2026115+₹10.07%332
01 Sep 2026113−₹20.07%329
31 Aug 2026115+₹20.07%324
28 Aug 2026113+₹20.07%332
27 Aug 2026111−₹10.07%336
26 Aug 2026112+₹10.07%336
25 Aug 2026111−₹30.07%334
24 Aug 2026114+₹10.08%326
21 Aug 2026113+₹20.08%332
20 Aug 2026110+₹20.07%334
19 Aug 2026108+₹40.07%338
18 Aug 2026105−₹50.07%353
17 Aug 2026110+₹00.07%333
14 Aug 2026110−₹70.07%332
13 Aug 2026116−₹10.08%319
12 Aug 2026117−₹20.08%319
11 Aug 2026119−₹10.08%301
10 Aug 2026120−₹10.08%296
07 Aug 2026121−₹30.08%293
06 Aug 2026124−₹20.09%290
05 Aug 2026126−₹10.09%283
04 Aug 2026127−₹60.09%279
03 Aug 2026133−₹40.09%262
31 Jul 2026137—0.10%263

ACUTAAS within Health Technology

Ranked #20 of 61 funded Health Technology stocks, carrying 1.6% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
18LENSKART
Lenskart Solutions Limited
₹1011.6%
19MANKIND
Mankind Pharma Limited
₹1001.6%
20ACUTAAS
Acutaas Chemicals Limited
₹1001.6%
21CIPLA
Cipla Limited
₹981.5%
22NEULANDLAB
Neuland Laboratories Limited
₹841.3%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.